HOME >> BIOLOGY >> NEWS
Innovative technology for production of new pharmaceuticals forms basis of new company

Ghent, Belgium & Espoo, Finland Plants produce a lot of valuable pharmaceuticals − but rather slowly and in small quantities. So, scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) have together with Ghent University and VTT Technical Research Centre of Finland developed a technology to increase the production of pharmaceuticals in plant cells. The technology forms the foundation for the new company SoluCel. This week, the authoritative scientific journal PNAS is publishing results from the researchers that confirm the importance of the new technology.

Plants take good care of us
Plants are by far our most important source of vital substances. We think automatically of food, but a great many pharmaceuticals come from plants as well. 25% of today's pharmaceuticals are vegetal − in total, they account for a worldwide turnover of 33 billion euro. Still, because plants are relatively slow producers, the production of these pharmaceuticals is not so straightforward. Therefore, in the 1980s, scientists directed all their attention to the use of plant cells as production units. These plant cells can, in fact, produce the same substances as the plants themselves, but they do it much more quickly.

VIB and VTT researchers make further progress
The cell cultures also have their limitations. The production of secondary metabolites, for example − which are important medically − is very limited. It's possible to modify cell cultures in a way that they do produce these substances in larger quantities, but this is a very time-consuming process. The VIB research group of Dirk Inz and Alain Goossens, together with the VTT research group of Kirsi-Marja Oksman-Caldentey and Heiko Rischer, has developed a technology that increases the production of these secondary metabolites in a highly targeted way, thus gaining precious time. By introducing alterations into the DNA of plant cells, they s
'"/>

Contact: Sooike Stoops
info@vib.be
32-92-446-611
VIB, Flanders Interuniversity Institute of Biotechnology
22-Mar-2006


Page: 1 2 3

Related biology news :

1. Innovative tagging technique may help researchers better protect fish stocks
2. Innovative research technique reveals another natural wonder in Yellowstone Park
3. Innovative subsea separation technology wins 2007 EUREKA environmental award
4. Innovative smallpox vaccine research study to be conducted at Case Medical Center
5. Ossur recognized with Frost & Sullivan 2006 Innovative Technology Award
6. Innovative projects help ORNL win 3rd straight DOE Pollution Prevention Award
7. Innovative method for creating a human cytomegalovirus vaccine outlined
8. Innovative research set to push boundaries of cancer care
9. Innovative coating could give medical implants a longer life
10. Innovative collaboration brings Arctic science into the classroom
11. AFCYBER holds science and technology symposium

Post Your Comments:
(Date:5/21/2013)... of all types become most deadly when they metastasize ... reached this stage, it becomes very difficult for doctors ... develop. Now, researchers at the University of Missouri have ... lymphoma tumor cells wherever they may be in the ... the MU College of Veterinary Medicine, says being able ...
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
(Date:5/21/2013)... path of insulin action in cells in precise detail ... understanding what goes wrong in diabetes. , The ... James from Sydney,s Garvan Institute of Medical Research, is ... prestigious journal Cell Metabolism . , First discovered ... role in the body because it helps us lower ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Fueling fitness on the final frontier 2Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
(Date:5/21/2013)... , May 21, 2013  Personal Genome ... use its proprietary methodologies and expertise in genomic ... kinase targets in collaboration with Blueprint Medicines.  PGDx ... at identifying genomic alterations in tumors, and Blueprint ... kinase inhibitors for a genetically defined patient population. ...
(Date:5/21/2013)... 2013 Inflamax scientists worked closely ... to design the study, which will provide critical ... models used in the study of allergy treatments, ... Challenge (NAC) models. Although both the models are ... date no direct comparison between the allergic responses ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 PathoGenetix, ... rapid bacterial strain typing, announced today that it has ... pathogenic E. coli strains obtained from the Centers for ... Sequence Scanning™ (GSS™) technology. The findings are detailed in ... of the American Society for Microbiology in Denver on ...
(Date:5/20/2013)... UAE (PRWEB) May 21, 2013 ... consultancy specializing in “game-changing” life science and health related ... Dalia Dergham to its International Project Team. Dergham's expertise ... even greater multi-cultural depth to Grace Century as it ... the globe. , Ms. Dergham holds both an under ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
Cached News: